About
Company Overview
Management
Board of Directors
Advisory Boards
Collaborations
Partner Collaborations
Scientific & Research Collaborations
Patients
Patients Overview
Current Studies
Sponsored
TakeAim Lymphoma
TakeAim Leukemia
Understanding Primary CNS Lymphoma
Compassionate Use Policy
Pipeline
Pipeline Overview
Emavusertib
(CA-4948)
Fimepinostat
CA-170
CA-327
Erivedge
®
Scientific Resources
Investors
Overview
Press Releases
Events and Presentations
Corporate Governance
Committee Composition
Contact the Board
Financial Information
SEC Filings
Annual Reports
IRS Form 8937
Stock Performance
Interactive Chart
Historical Stock Lookup
Analyst Coverage
Contact Us
Careers
Life at Curis
Open Positions
Benefits
Contact
About
Company Overview
Management
Board of Directors
Advisory Boards
Collaborations
Partner Collaborations
Scientific & Research Collaborations
Patients
Patients Overview
Current Studies
Sponsored
TakeAim Lymphoma
TakeAim Leukemia
Understanding Primary CNS Lymphoma
Compassionate Use Policy
Pipeline
Pipeline Overview
Emavusertib
(CA-4948)
Fimepinostat
CA-170
CA-327
Erivedge
®
Scientific Resources
Investors
Overview
Press Releases
Events and Presentations
Corporate Governance
Committee Composition
Contact the Board
Financial Information
SEC Filings
Annual Reports
IRS Form 8937
Stock Performance
Interactive Chart
Historical Stock Lookup
Analyst Coverage
Contact Us
Careers
Life at Curis
Open Positions
Benefits
Contact
Phase 1 Study of CI-8993 Anti-VISTA Antibody in Patients with Advanced Solid Tumor Malignancies
About
Company Overview
Management
Board of Directors
Advisory Boards
Collaborations
Partner Collaborations
Scientific & Research Collaborations
Patients
Patients Overview
Current Studies
Sponsored
TakeAim Lymphoma
TakeAim Leukemia
Understanding Primary CNS Lymphoma
Compassionate Use Policy
Pipeline
Pipeline Overview
Emavusertib
(CA-4948)
Fimepinostat
CA-170
CA-327
Erivedge
®
Scientific Resources
Investors
Overview
Press Releases
Events and Presentations
Corporate Governance
Committee Composition
Contact the Board
Financial Information
SEC Filings
Annual Reports
IRS Form 8937
Stock Performance
Interactive Chart
Historical Stock Lookup
Analyst Coverage
Contact Us
Careers
Life at Curis
Open Positions
Benefits
Contact